34.Girn-Arango L, Perlas A (2024) Point-of-care gastric ultrasound to identify a full stomach on a diabetic patient taking a glucagon-like peptide 1 receptor agonist
[DOI] [PMC free article] [PubMed] [Google Scholar] 229.Eberly L.A., Yang L., Essien U.R., Eneanya N.D., Julien H.M., Luo J., Nathan A.S., Khatana S.A.M., Dayoub E.J., Fanaroff A.C., et al
Diet, activity levels, and sleep quality can all impact how effective each dose feels
Drucker Potential cellular targets mediating the antiinflammatory effects of GLP-1 medicines.
Other diabetes medications such as metformin or SGLT2 inhibitors can usually be continued safely alongside GLP-1 treatment
used for general metabolic interest